Published in Acta Physiol Scand on March 01, 1981
A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. Proc Natl Acad Sci U S A (1983) 2.64
Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiol (1983) 2.42
The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol (1982) 1.88
Some rat sensory neurons in culture express characteristics of differentiated pain sensory cells. Proc Natl Acad Sci U S A (1983) 1.57
Studies on the trigeminal antidromic vasodilatation and plasma extravasation in the rat. J Physiol (1984) 1.13
Evidence that the contractile response of the guinea-pig ileum to capsaicin is due to release of substance P. J Physiol (1982) 0.96
Interaction of neurotensin with the substance P receptor mediating histamine release from rat mast cells and the flare in human skin. Br J Pharmacol (1982) 0.95
Pain--mechanics and management. West J Med (1984) 0.86
Immunocytochemical investigation of neurovascular relationships in human tooth pulp. J Anat (2003) 0.80
New concepts of vascular headache. Ann R Coll Surg Engl (1993) 0.77
Trigeminal antidromic vasodilatation and plasma extravasation in the rat: effects of acetylcholine antagonists and cholinesterase inhibitors. Br J Pharmacol (1985) 0.76
International Substance P Symposium. Dublin, April 27-29, 1983. Abstracts. Ir J Med Sci (1983) 0.75
Crystalline Vitamin B12. Science (1948) 8.37
Comparative Data on Vitamin B12 From Liver and From a New Source, Streptomyces griseus. Science (1948) 4.81
STREPTOMYCES ANTIBIOTICS. III. DEGRADATION OF STREPTOMYCIN TO STREPTOBIOSAMINE DERIVATIVES. Science (1945) 3.59
A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. Proc Natl Acad Sci U S A (1983) 2.64
Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide. Biochem Biophys Res Commun (1971) 2.07
STREPTOMYCES ANTIBIOTICS. I. CRYSTALLINE SALTS OF STREPTOMYCIN AND STREPTOTHRICIN. Science (1945) 1.98
A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation. Nature (1981) 1.76
The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem Biophys Res Commun (1969) 1.62
Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria. J Intern Med (2008) 1.54
Vitamin B12, A Cobalt Complex. Science (1948) 1.53
Chemical design of antagonists of substance P. Acta Physiol Scand (1981) 1.49
Activity and specificity of synthetic thyrotropin-releasing hormone in man. Biochem Biophys Res Commun (1970) 1.47
Release of free fatty acids from subcutaneous adipose tissue in dogs following sympathetic nerve stimulation. Acta Physiol Scand (1967) 1.47
2-multiprenylphenols and 2-decaprenyl-6-methoxyphenol, biosynthetic precursors of ubiquinones. J Am Chem Soc (1966) 1.43
Mass spectra of ubiquinones and ubiquinols. J Am Chem Soc (1967) 1.42
The pharmacological profile of a substance P (SP) antagonist. Evidence for the existence of subpopulations of SP receptors. Acta Physiol Scand (1983) 1.40
Cigarette smoke-induced airway oedema due to activation of capsaicin-sensitive vagal afferents and substance P release. Neuroscience (1983) 1.40
Biological evaluation of substance P antagonists. Br J Pharmacol (1984) 1.39
New multiprenylquinones in the biosynthesis of ubiquinone. Biochem Biophys Res Commun (1967) 1.35
Piericidin A: a new inhibitor of mitochondrial electron transport. Biochem Biophys Res Commun (1966) 1.32
Release of substance P-like immunoreactivity from the dental pulp. Acta Physiol Scand (1977) 1.30
Impaired acetylcholine-induced vascular relaxation in low birth weight infants: implications for adult hypertension? Pediatr Res (2000) 1.25
A synthetic peptide that is a bombesin receptor antagonist. Nature (1984) 1.24
Effect of topical application of coenzyme Q10 on adult periodontitis. Mol Aspects Med (1994) 1.21
Lovastatin decreases coenzyme Q levels in rats. Proc Natl Acad Sci U S A (1990) 1.20
A substance P antagonist, [D-Pro2, D-Trp7,9]SP, inhibits inflammatory responses in the rabbit eye. Science (1981) 1.20
The effect of ingestion of amino acids, glucose and fat on circulating neurotensin-like immunoreactivity (NTLI) in man. Acta Physiol Scand (1979) 1.19
Deficiency of coenzyme Q 10 in human heart disease. II. Int J Vitam Nutr Res (1972) 1.19
Laser Doppler flowmetry in assessing vitality in luxated permanent teeth. Int Endod J (1988) 1.18
Discovery of inhibitory activity of tenuazonic acid for growth of human adenocarcinoma-1. Biochem Biophys Res Commun (1964) 1.15
Determination of biosynthetic precursors from p-hydroxybenzoic acid-U-14C to ubiquinone. Anal Biochem (1968) 1.13
Presence of substance P-like immunoreactivity in plasma from man and dog. Acta Physiol Scand (1975) 1.13
Deficiency of coenzyme Q 10 in human heart disease. I. Int J Vitam Nutr Res (1972) 1.12
Deficiency of coenzyme Q 10 in gingival tissue from patients with periodontal disease. Proc Natl Acad Sci U S A (1971) 1.12
Evidence for a deficiency of coenzyme Q10 in human heart disease. Int Z Vitaminforsch (1970) 1.11
Inhibition of gastric and intestinal motor activity in dogs by (Gln4) neurotensin. Acta Physiol Scand (1977) 1.10
Clinical results of a cross-over treatment with pyridoxine and placebo of the carpal tunnel syndrome. Am J Clin Nutr (1979) 1.10
The mechanism of action of a substance P antagonist (D-Pro2, D-Trp7,9)-SP. Br J Pharmacol (1982) 1.09
Abnormal afferent nerve endings in the soft palatal mucosa of sleep apnoics and habitual snorers. Regul Pept (1997) 1.09
Response of vitamin B-6 deficiency and the carpal tunnel syndrome to pyridoxine. Proc Natl Acad Sci U S A (1982) 1.08
Effect of mistletoe viscotoxin and phoratoxin on blood circulation. Toxicon (1966) 1.07
Deficiency of coenzyme Q in gingiva of patients with periodontal disease. Int J Vitam Nutr Res (1973) 1.07
Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. Proc Natl Acad Sci U S A (1985) 1.07
SYNTHETIC VITAMIN B6. Science (1939) 1.06
Neurotensin increases colonic motility. Gastroenterology (1986) 1.05
Synthetic thyrotropin-releasing hormone. Activity in men and women, specificity of action, inhibition by triiodothyronine, and activity orally. J Med Chem (1971) 1.05
A substance P antagonist inhibits a slow reflex response in the spinal cord of the newborn rat. Acta Physiol Scand (1982) 1.05
Inhibition of mitochondrial electron transport by piericidin A and related compounds. Biochemistry (1968) 1.04
The effect of food ingestion on circulating neurotensin-like immunoreactivity (NTLI) in the human. Acta Physiol Scand (1978) 1.04
Blood circulation in adipose tissue. Physiol Rev (1979) 1.04
Report on a patient with watery diarrhoea syndrome caused by a pancreatic tumour containing neurotensin, enkephalin and calcitonin. Acta Med Scand (1980) 1.04
Rhodanine: a selective inhibitor of the multiplication of echovirus 12. Science (1970) 1.03
Biochemical evidence for a deficiency of vitamin B6 in the carpal tunnel syndrome based on a crossover clinical study. Proc Natl Acad Sci U S A (1978) 1.03
The influence of sympathetic activity and histamine on the blood-tissue exchange of solutes in canine adipose tissue. Acta Physiol Scand (1974) 1.02
Treatment of essential hypertension with coenzyme Q10. Mol Aspects Med (1994) 1.02
Ultrastructure of nerves in the dentinal-pulp border zone after sensory and autonomic nerve transection in the cat. Acta Odontol Scand (1973) 1.02
Pharmacological characterization of four related substance P antagonists. Acta Physiol Scand (1982) 1.02
Bioenergetics in clinical medicine. II. Adjunctive treatment with coenzyme Q in periodontal therapy. Res Commun Chem Pathol Pharmacol (1975) 1.01
A synthetic peptide as an antagonist of substance P. Nature (1981) 1.01
Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy. Am J Cardiol (1990) 1.01
Biosynthesis of vitamin B12. Different pathways in some aerobic and anaerobic microorganisms. Arch Microbiol (1982) 1.01
Evidence for enhanced treatment of periodontal disease by therapy with coenzyme Q. Int J Vitam Nutr Res (1973) 1.01
Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity. Biochem Biophys Res Commun (1974) 1.01
Non-invasive recording of blood flow in human dental pulp. Endod Dent Traumatol (1986) 1.00
Human deficiencies of vitamin B6. I. Studies on parameters of the assay of the glutamic oxaloacetic transaminase by the CAS principle. Res Commun Chem Pathol Pharmacol (1975) 1.00
Clinical aspects of treatment of carpal tunnel syndrome with vitamin B6. Ann N Y Acad Sci (1990) 1.00
The roles of coenzyme Q10 and vitamin E on the peroxidation of human low density lipoprotein subfractions. Proc Natl Acad Sci U S A (1995) 0.99
Improved and effective assays of the glutamic oxaloacetic transaminase by the coenzyme-apoenzyme system (CAS) principle. J Nutr Sci Vitaminol (Tokyo) (1976) 0.99
Localization of substance P-like immunoreactivity in nerves in the tooth pulp. Pain (1977) 0.99
Micro-analysis for coenzyme Q10 in endomyocardial biopsies of cardiac patients and data on bovine and canine hearts. Biochem Biophys Res Commun (1984) 0.98
Discovery of ubiquinones-1,-2,-3, and -4 and the nature of biosynthetic isoprenylation. Biochemistry (1967) 0.98
Effective and safe therapy with coenzyme Q10 for cardiomyopathy. Klin Wochenschr (1988) 0.97
Non-adrenergic, non-cholinergic salivary secretion in the ferret. Q J Exp Physiol (1988) 0.97
Discovery of modification of the synthetic tripeptide-sequence of the thyrotropin releasing hormone having activity. Biochem Biophys Res Commun (1969) 0.97
Evidence that substance P is a mediator of antidromic vasodilatation using somatostatin as a release inhibitor. Acta Physiol Scand (1981) 0.97
Blood flow, oxygen consumption, and free fatty acid release in subcutaneous adipose tissue during hemorrhagic shock in control and phenoxybenzamine-treated dogs. Circ Res (1970) 0.96
Synthesis of rhodoquinone and other multiprenyl-1,4-benzoquinones biosynthetically related to ubiquinone. J Am Chem Soc (1968) 0.96
Vasodilatory effects and coexistence of calcitonin gene-related peptide (CGRP) and substance P in sensory nerves of cat dental pulp. Acta Physiol Scand (1987) 0.96
The synthesis of tenuazonic and congeneric tetramie acids. J Med Chem (1965) 0.95
Kinetics of the reoxidation of succinate dehydrogenase. Arch Biochem Biophys (1977) 0.95
Low molecular weight analogs of coenzyme Q as hydrogen acceptors and donors in systems of the respiratory chain. Biochem Biophys Res Commun (1975) 0.95
(Gln4)-neurotensin changes the motility pattern of the duodenum and proximal jejunum from a fasting-type to a fed-type. Gastroenterology (1982) 0.94
In vivo release of substance P in cat dorsal horn studied with microdialysis. Neurosci Lett (1987) 0.94